<< Back To Search

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

Notify the Multiple Myeloma Research Foundation you are interested in this trial
NCT04731844
Age 18 +
Sex Both
Phase Phase 2
Third Opinion Trial Synopsis
This research study wants to see if taking a combination of curcumin and piperine supplements twice a day can help people with early stage prostate cancer or a certain type of blood disease called MGUS/smoldering myeloma. They will use a dose of 4 grams of curcumin and 5 milligrams of piperine.
Third Opinion AI Generated Synopsis

Trial Summary
To explore the use of curcumin and piperine supplementation at a dose of 4 gram/5mg twice a day in early stage prostate cancer patient undergoing active surveillance or patients on observation for MGUS/ low-risk smoldering myeloma.
from ClinicalTrials.gov

Locations & Contact

Fill out the form and to let the Multiple Myeloma Research Foundation know you are interested in this trial.

Please share any additional considerations or concerns:
Example: Are you newly diagnosed? What treatments have you already been on?

Contacts: